Report DMCA A phase II study of daily carboplatin plus irradiation followed by durvalumab for stage III non-small cell lung cancer p
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.